6533b82afe1ef96bd128b7b2

RESEARCH PRODUCT

Anti-adrenergic effects of ranolazine in isolated rat aorta

MauricioMartin AldasoroDiana Aguirre-ruedaFb El AmraniSoraya L. VallesS GuerraJose Mª VilaPatricia Marchio

subject

DrugAortaEndotheliumbusiness.industrymedia_common.quotation_subjectRanolazineAdrenergicChronic anginaBlood flowIschemic ContracturePharmacologyCritical Care and Intensive Care Medicinemedicine.anatomical_structuremedicine.arteryPoster Presentationmedicinebusinessmedicine.drugmedia_common

description

Ranolazine, a piperazine derivative, is used as an anti- anginal drug to treat patients with chronic angina in clinical practice [1] and may improve coronary blood flow by reducing compression effects of ischemic contracture, and by improving endothelial function [2],[3]. In the present study we investigate the vascular effects of ranolazine on the endothelium, adrenergic system and Ca2+ in isolated rat aorta.

10.1186/cc13374http://europepmc.org/articles/PMC4068193